Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CrossAmerica Partners (CAPL) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for CrossAmerica Partners (CAPL) over the last 14 years, with Q3 2025 value amounting to $826000.0.

  • CrossAmerica Partners' Gains from Investment Securities rose 576.18% to $826000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.2 million, marking a year-over-year increase of 606.46%. This contributed to the annual value of $3.1 million for FY2024, which is 664.36% up from last year.
  • Per CrossAmerica Partners' latest filing, its Gains from Investment Securities stood at $826000.0 for Q3 2025, which was up 576.18% from $813000.0 recorded in Q2 2025.
  • In the past 5 years, CrossAmerica Partners' Gains from Investment Securities ranged from a high of $826000.0 in Q3 2025 and a low of $633000.0 during Q1 2021
  • Over the past 5 years, CrossAmerica Partners' median Gains from Investment Securities value was $719000.0 (recorded in 2023), while the average stood at $722631.6.
  • Per our database at Business Quant, CrossAmerica Partners' Gains from Investment Securities skyrocketed by 382.26% in 2022 and then surged by 695.41% in 2024.
  • CrossAmerica Partners' Gains from Investment Securities (Quarter) stood at $660000.0 in 2021, then rose by 5.15% to $694000.0 in 2022, then rose by 6.63% to $740000.0 in 2023, then increased by 6.49% to $788000.0 in 2024, then increased by 4.82% to $826000.0 in 2025.
  • Its last three reported values are $826000.0 in Q3 2025, $813000.0 for Q2 2025, and $791000.0 during Q1 2025.